.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Citi
Baxter
Merck
Express Scripts
Fuji
Covington
QuintilesIMS
Boehringer Ingelheim
Cipla

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076451

« Back to Dashboard
NDA 076451 describes FLUTICASONE PROPIONATE, which is a drug marketed by Fougera Pharms, West-ward Pharms Int, Tolmar, Apotex Inc, Taro Pharm Inds, Perrigo Israel, G And W Labs, Glenmark Generics, Nesher Pharms, Perrigo New York, Hi Tech Pharma, and Wockhardt, and is included in seventeen NDAs. It is available from sixty-seven suppliers. Additional details are available on the FLUTICASONE PROPIONATE profile page.

The generic ingredient in FLUTICASONE PROPIONATE is fluticasone propionate. There are twenty-two drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

Summary for NDA: 076451

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076451

Suppliers and Packaging for NDA: 076451

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUTICASONE PROPIONATE
fluticasone propionate
CREAM;TOPICAL 076451 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0332 0168-0332-15 15 g in 1 TUBE (0168-0332-15)
FLUTICASONE PROPIONATE
fluticasone propionate
CREAM;TOPICAL 076451 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0332 0168-0332-30 30 g in 1 TUBE (0168-0332-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:May 14, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
Teva
Cantor Fitzgerald
Mallinckrodt
Dow
Federal Trade Commission
Deloitte
Cerilliant
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot